Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Net Issuance of Common Stock
Prestige Consumer Healthcare Inc
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Net Issuance of Common Stock
-$14m
|
CAGR 3-Years
2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Common Stock
$2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Common Stock
-$4.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
34%
|
CAGR 10-Years
14%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prestige Consumer Healthcare Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
-14m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Net Issuance of Common Stock amounts to -14m USD.
What is Prestige Consumer Healthcare Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
21%
Over the last year, the Net Issuance of Common Stock growth was 66%. The average annual Net Issuance of Common Stock growth rates for Prestige Consumer Healthcare Inc have been 2% over the past three years , 21% over the past five years .